Author

YongHyun Cho

Institution: Kakao Corporation (South Korea)

Observed institution: Kakao Corporation (South Korea)

ORCID: 0000-0002-8606-0295

Observed ORCID: 0000-0002-8606-0295

OpenAlex ID: A5046386770

Electronic Medical Record–Based Machine Learning Approach to Predict the Risk of 30-Day Adverse Cardiac Events After Invasive Coronary Treatment: Machine Learning Model Development and Validation

2022 · Osung Kwon, Wonjun Na, et al. · JMIR Medical Informatics · 15

Comparative effectiveness of pioglitazone and sitagliptin added to metformin and sulfonylurea in patients with type 2 diabetes: An emulated target trial

2026 · Tae Hyeon Kim, Yerin Hwang, et al. · Medicine

Long-term effectiveness on glycemic control of insulin compared to combined oral antidiabetic drugs for initial intensive treatment in newly diagnosed type 2 diabetes: A duplicated target trial

2026 · Tae Hyeon Kim, Yerin Hwang, et al. · Medicine

Comparative effectiveness of metformin and alogliptin combination therapy versus metformin monotherapy in patients with type 2 diabetes: an emulated target trial

2025 · Jaehyeong Cho, Yerin Hwang, et al. · BMC Endocrine Disorders

Works count: 5

Citation count: 15

H-index: 1

I10-index: 1